S. Wittebol
Impact in
- Hematology top 2%
- Multiple Myeloma Research and Treatments
- Acute Myeloid Leukemia Research
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 10
- Acute Myeloid Leukemia Research 5
- Multiple Myeloma Research and Treatments 3
- Chronic Myeloid Leukemia Treatments 2
- Genetics 5
- Chronic Lymphocytic Leukemia Research 3
- Co-authors
- Bob Löwenberg (4 shared papers)Pieter Sonneveld (4 shared papers)Michael S. van der Veer (1 shared paper)Paul W.H.I. Parren (1 shared paper)Berris van Kessel (1 shared paper)Joost M. Bakker (1 shared paper)HM Lokhorst (1 shared paper)Michel de Weers (1 shared paper)
- Journals
- Blood (3 papers)Haematologica (2 papers)Leukemia (2 papers)Clinical Infectious Diseases (1 paper)British Journal of Haematology (1 paper)
- Partner nations
- NetherlandsBelgiumUnited States
In The Last Decade
S. Wittebol
16 papers receiving 596 citations
Peers
Comparison fields: 5 of 52
- Hematology 365
- Genetics 106
- Oncology 245
- Physiology 28
- Pediatrics, Perinatology and Child Health 72
Countries citing papers authored by S. Wittebol
This map shows the geographic impact of S. Wittebol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Wittebol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Wittebol more than expected).
Fields of papers citing papers by S. Wittebol
This network shows the impact of papers produced by S. Wittebol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Wittebol. The network helps show where S. Wittebol may publish in the future.
Co-authors
The 25 scholars most cited alongside S. Wittebol, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 173 | |
| 2 | 1993 | 136 | |
| 3 | 1999 | 80 | |
| 4 | 2011 | 62 | |
| 5 | 2015 | 38 | |
| 6 | 1996 | 28 | |
| 7 | 2009 | 19 | |
| 8 | Molecular diversity in AML1/ETO fusion transcripts in patients with t(8;21) positive acute myeloid leukaemia. | 1994 | 19 |
| 9 | Residual normal, highly proliferative progenitors can be isolated from the CD34+/33- fraction of AML with a more differentiated phenotype (CD33+). | 1995 | 19 |
| 10 | 1998 | 14 | |
| 11 | 2013 | 8 | |
| 12 | 2009 | 6 | |
| 13 | 1993 | 6 | |
| 14 | Dutch guidelines for diagnosis and treatment of chronic lymphocytic leukaemia 2011. | 2011 | 4 |
| 15 | [Immunologic phenomena as the first sign of myelodysplastic syndrome]. | 2001 | 2 |
| 16 | [Acquired von Willebrand syndrome]. | 2003 | 2 |
About S. Wittebol
S. Wittebol is a scholar working on Hematology, Genetics, Molecular Biology, Oncology and Pathology and Forensic Medicine, having authored 16 papers that have together received 616 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (5 papers), Multiple Myeloma Research and Treatments (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), Chronic Myeloid Leukemia Treatments (2 papers), Acute Lymphoblastic Leukemia research (2 papers), Childhood Cancer Survivors' Quality of Life (2 papers), Lymphoma Diagnosis and Treatment (2 papers) and Cancer therapeutics and mechanisms (2 papers). The work is most often cited by research in Hematology (365 citations), Genetics (106 citations), Oncology (245 citations), Physiology (28 citations) and Pediatrics, Perinatology and Child Health (72 citations). S. Wittebol has collaborated with scholars based in Netherlands, Belgium and United States. Frequent co-authors include Bob Löwenberg, Pieter Sonneveld, Michael S. van der Veer, Paul W.H.I. Parren, Berris van Kessel, Joost M. Bakker, HM Lokhorst, Michel de Weers, Tuna Mutis and K. De Leeuw. Their work appears in journals such as Blood, Haematologica, Leukemia, Clinical Infectious Diseases and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.